Overview
In this lunch-and-learn program, two seasoned FDA lawyers and an FDA career coach will share their insights and then take questions about how to flourish as an FDA lawyer. Further, this trio will discuss different FDA lawyer career options: in house vs. law firm, legislative or executive branch vs. trade associations or non-profit options, and more. You’ll also learn how to make the most of conferences and networking events, the pros and cons of building your specific “brand” vs. being a generalist, and how to perform your own “FDA career audit”. Finally, the “Career Doctor is in”—anonymous requests handled confidentially. Please submit your career questions to Paige Samson ([email protected]) so that the panel can address any questions you may have in a confidential manner during the program.
Speakers
Stuart TenHoor, Career Coach, Stuart TenHoor Legal Search
Mark Raza, Principal Deputy Chief Counsel, Office of Chief Counsel, FDA
Kellie B. Combs, Partner, Ropes & Gray LLP
Register
This program is limited to those who are a part of NFDL. This complimentary program includes a light lunch. Please register by February 11, 2020 to reserve your spot.
New to Food and Drug Law Group
The New to Food and Drug Law Group (NFDL) offers young professionals with up to six years of experience an opportunity to connect, learn from their peers, and enhance their skills. Individuals affiliated with member organizations, those employed by the government, and law students are encouraged to participate.
For questions, please contact Paige Samson.

STUART TENHOOR has been a “career coach first, executive recruiter second” for more than 30 years, working in the Greater Washington, DC area legal community for all that time. His passion for the food and drug legal community has been long term (but was partly sparked by a T.V. commercial 10 years ago!). The focus of his career coaching practice is life science attorneys.
MARK RAZA is the Principal Deputy Chief Counsel in FDA’s Office of the Chief Counsel (OCC). In almost 30 years in OCC, Mark has served as a trial attorney handling both civil and criminal litigation; has worked in the counseling areas of biologics,information disclosure, and international/import/export law, among others; and has managed the OCC device, combination products, emergency preparedness and response, leveraging, human subject protection, and Commissioner’s administrative litigation teams. He has served as an agency ratifier for device and animal drug user fee reauthorization. He has also served details as the Acting Associate Center Director for Policy and Regulation in CDRH, and as an Acting Associate Director in the former Office of Therapeutics Research and Review in CBER. He is a graduate of Harvard Law School and Boston College
KELLIE COMBS is Partner in the Life Sciences group at Ropes & Gray LLP, where she provides legal and strategic advice to pharmaceutical, biotechnology, and medical device manufacturers on a broad range of issues under the Food, Drug, and Cosmetic Act and the Public Health Service Act. Kellie has extensive experience handling matters implicating FDA promotional rules and the First Amendment and also routinely advises clients on lifecycle management, regulation of clinical research, digital health, and post-approval compliance. In addition, she conducts regulatory due diligence in connection with transactions involving life sciences clients and advises on government investigations of FDA-regulated companies. 
